MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijrobp.2025.01.032

Медицинская библиотека · International journal of radiation oncology, biology, physics · 2025

Carbon Ion Radiation Therapy with Pencil Beam Scanning for Stage III Non-Small Cell Lung Cancer: Toxicity Profiles, Survival Outcomes, and Prognostic Indicators.

Ma Ningyi, Ming Xue, Chen Jian, Jiang Guo-Liang, Wu Kai-Liang, Mao Jingfang

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: To evaluate the toxicities and survival outcomes associated with carbon ion radiation therapy (CIRT) using pencil beam scanning (PBS) technique and to assess the prognostic factors for patients with stage III non-small cell lung cancer (NSCLC) using a local effect model (LEM)-based biological dose calculation.

METHODS AND MATERIALS: This analysis included patients with stage III NSCLC (n = 181) who received CIRT between December 2016 and June 2023. CIRT was administered at a relative biological effectiveness-weighted dose of 77 Gy (range, 69-83.6 Gy) in 22 fractions (Fx) (range, 19-24 Fx). Most patients (96.1%) underwent systemic therapy before and/or after CIRT. Toxicities and survival outcomes were recorded, and statistical analyses conducted.

RESULTS

The median follow-up period was 18.2 months. Grade 1, 2, 3, and 4 acute toxicities were observed in 62.4%, 30.4%, 2.8%, and 0.6% of patients, respectively, with hematological toxicities accounting for all grade ≥ 3 acute toxicities. Grade 1, 2, 3, and 4 late toxicities occurred in 40.3%, 30.9%, 4.4%, and 1.7% of patients, respectively, with most grade ≥ 3 CIRT-induced late toxicities (72.7%) observed in patients receiving a CIRT dose ≥ 79.2 Gy. The median overall survival (OS) and progression-free survival (PFS) were 37.1 and 16.7 months, respectively. The 2-year locoregional control, OS, PFS, and distant metastasis-free survival rates were 66.1%, 64.2%, 40.3%, and 49.5%, respectively. Patients who received a CIRT dose ≤ 77 Gy had better OS (P = .047), but worse locoregional control compared with those who received higher doses (P = .026). Post-CIRT immunotherapy was an independent prognostic factor for improved OS, distant metastasis-free survival, and PFS (P = .002, P < .001, and P < .001, respectively).

CONCLUSIONS

CIRT with pencil beam scanning was effective for locally advanced NSCLC, resulting in acceptable toxicities and promising OS outcomes, particularly with doses of 69 to 77 Gy and post-CIRT immunotherapy.

Для цитирования: Ma Ningyi, Ming Xue, Chen Jian, Jiang Guo-Liang, Wu Kai-Liang, Mao Jingfang. Carbon Ion Radiation Therapy with Pencil Beam Scanning for Stage III Non-Small Cell Lung Cancer: Toxicity Profiles, Survival Outcomes, and Prognostic Indicators.. International journal of radiation oncology, biology, physics. 2025. DOI: 10.1016/j.ijrobp.2025.01.032.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.